172 related articles for article (PubMed ID: 8680545)
1. Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.
Hirayama C; Suzuki H; Takada A; Fujisawa K; Tanikawa K; Igarashi S
J Gastroenterol; 1996 Apr; 31(2):242-8. PubMed ID: 8680545
[TBL] [Abstract][Full Text] [Related]
2. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
Sato S
Nihon Shokakibyo Gakkai Zasshi; 1992 Sep; 89(9):2007-15. PubMed ID: 1404988
[TBL] [Abstract][Full Text] [Related]
4. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum 7S collagen in various liver diseases.
Yamada S; Suou T; Kawasaki H; Yoshikawa N
Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
7. Serum type I collagen propeptide and severity of alcoholic liver disease.
Niemelä O; Blake JE; Orrego H
Alcohol Clin Exp Res; 1992 Dec; 16(6):1064-7. PubMed ID: 1471760
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.
Ala-Kokko L; Günzler V; Hoek JB; Rubin E; Prockop DJ
Hepatology; 1992 Jul; 16(1):167-72. PubMed ID: 1618469
[TBL] [Abstract][Full Text] [Related]
9. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.
Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A
Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases.
Ueno T; Tamaki S; Sugawara H; Inuzuka S; Torimura T; Sata M; Tanikawa K
J Hepatol; 1996 Feb; 24(2):177-84. PubMed ID: 8907571
[TBL] [Abstract][Full Text] [Related]
12. Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis.
Trivedi P; Risteli J; Risteli L; Tanner MS; Bhave S; Pandit AN; Mowat AP
Hepatology; 1987; 7(6):1249-53. PubMed ID: 3679089
[TBL] [Abstract][Full Text] [Related]
13. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Gastroenterology; 1990 Jun; 98(6):1612-9. PubMed ID: 1692550
[TBL] [Abstract][Full Text] [Related]
14. [Serum laminin and portal pressure in alcoholic cirrhosis. A study of 39 patients].
Mal F; Hartmann DJ; Trinchet JC; Lacombe F; Ville G; Beaugrand M
Gastroenterol Clin Biol; 1988 Nov; 12(11):841-4. PubMed ID: 3220234
[TBL] [Abstract][Full Text] [Related]
15. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis.
Castera L; Hartmann DJ; Chapel F; Guettier C; Mall F; Lons T; Richardet JP; Grimbert S; Morassi O; Beaugrand M; Trinchet JC
J Hepatol; 2000 Mar; 32(3):412-8. PubMed ID: 10735610
[TBL] [Abstract][Full Text] [Related]
16. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
17. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity.
Lotterer E; Gressner AM; Kropf J; Grobe E; von Knebel D; Bircher J
J Hepatol; 1992 Jan; 14(1):71-7. PubMed ID: 1737919
[TBL] [Abstract][Full Text] [Related]
19. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
